Literature DB >> 3353389

Desensitization of rat renal thick ascending limb cells to vasopressin.

J M Elalouf1, D C Sari, N Roinel, C de Rouffignac.   

Abstract

Previous studies from this laboratory have demonstrated that vasopressin stimulates K, Mg, Ca, Cl, and Na reabsorption by the thick ascending limb of Henle's loop (TALH) of the rat kidney. Micropuncture of superficial nephrons and clearance experiments were performed to determine whether desensitization of the TALH to vasopressin may be demonstrated in vivo and whether such desensitization is specific for the effects of vasopressin (i.e., homologous) or also alters the response to the other hormones acting on the same pool of adenylate cyclase in this nephron segment. Brattleboro rats, with hereditary hypothalamic diabetes insipidus (DI), were given i.m. injections of 1-desamino-8-D-arginine-vasopressin (des-1-amino-[DArg8]VP (herein designated dDAVP); 2 micrograms/day) for 3 days. The effects of maximal physiological doses of arginine-8-vasopressin ([Arg8]VP (herein designated AVP); 20 pg/min per 100 g of body weight) were studied 2 days after the cessation of treatment, when the animals had returned to DI. The K, Mg, Ca, and, to a lesser extent, Cl and Na concentrations in the fluid leaving the TALH of superficial nephrons were higher in dDAVP-treated than in untreated rats given similar amounts of AVP during the experiments. A 50-60% desensitization of the TALH to AVP was still apparent 2 days after stopping the dDAVP injections. Desensitization is homologous, as judged from normal responses to physiological doses of glucagon and calcitonin, two hormones acting on the same cyclase pool as AVP in the rat TALH. The AVP-dependent increase of urine osmolality, however, indicated that its effects on the permeability to water of the collecting duct were scarcely affected in dDAVP-treated rats. It is concluded that (i) AVP induces homologous desensitization in the rat TALH and (ii) the TALH can be markedly desensitized to AVP when the collecting duct response to this hormone is poorly affected or even fully maintained.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3353389      PMCID: PMC280002          DOI: 10.1073/pnas.85.7.2407

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Familial hypothalamic diabetes insipidus in rats.

Authors:  H VALTIN; H A SCHROEDER; K BENIRSCHKE; H W SOKOL
Journal:  Nature       Date:  1962-12-15       Impact factor: 49.962

2.  Effects of in vivo treatment with vasopressin and analogues on renal adenylate cyclase responsiveness to vasopressin stimulation in vitro.

Authors:  R M Rajerison; D Butlen; S Jard
Journal:  Endocrinology       Date:  1977-07       Impact factor: 4.736

3.  The mechanism of glucagon-induced natriuresis in dogs.

Authors:  M Levy; N L Starr
Journal:  Kidney Int       Date:  1972-08       Impact factor: 10.612

4.  Effects of vasopressin on water and NaCl transport across the in vitro perfused medullary thick ascending limb of Henle's loop of mouse, rat, and rabbit kidneys.

Authors:  S Sasaki; M Imai
Journal:  Pflugers Arch       Date:  1980-02       Impact factor: 3.657

5.  Vasopressin-elicited refractoriness of the response to vasopressin in toad urinary bladder.

Authors:  J S Handler; A S Preston
Journal:  Am J Physiol       Date:  1981-06

6.  Catecholamine-specific desensitization of adenylate cyclase. Evidence for a multistep process.

Authors:  Y F Su; T K Harden; J P Perkins
Journal:  J Biol Chem       Date:  1980-08-10       Impact factor: 5.157

7.  Structural requirements for activation of vasopressin-sensitive adenylate cyclase, hormone binding, and antidiuretic actions: effects of highly potent analogues and competitive inhibitors.

Authors:  D Butlen; G Guillon; R M Rajerison; S Jard; W H Sawyer; M Manning
Journal:  Mol Pharmacol       Date:  1978-11       Impact factor: 4.436

8.  Synthesis and some pharmacological properties of deamino(4-threonine,8-D-arginine)vasopressin and deamino(8-D-arginine)vasopressin, highly potent and specific antidiuretic peptides, and (8-D-arginine)vasopressin and deamino-arginine-vasopressin.

Authors:  M Manning; L Balaspiri; J Moehring; J Haldar; W H Sawyer
Journal:  J Med Chem       Date:  1976-06       Impact factor: 7.446

9.  Vasopressin-dependent adenylate cyclase activities in the rat kidney medulla: evidence for two separate sites of action.

Authors:  M Imbert-Teboul; D Chabardès; M Montégut; A Clique; F Morel
Journal:  Endocrinology       Date:  1978-04       Impact factor: 4.736

10.  Gonadotropin-induced regulation of luteinizing hormone receptors and desensitization of testicular 3':5'-cyclic AMP and testosterone responses.

Authors:  A J Hsueh; M L Dufau; K J Catt
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

View more
  3 in total

1.  In vitro desensitization of isolated nephron segments to vasopressin.

Authors:  I Dublineau; P Pradelles; C de Rouffignac; J M Elalouf
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

2.  Molecular analysis of vasopressin receptors in the rat nephron. Evidence for alternative splicing of the V2 receptor.

Authors:  D Firsov; B Mandon; A Morel; J Merot; S Le Maout; A C Bellanger; C de Rouffignac; J M Elalouf; J M Buhler
Journal:  Pflugers Arch       Date:  1994-11       Impact factor: 3.657

3.  Hormone-mediated Ca2+ transients in isolated renal cortical thick ascending limb cells.

Authors:  L J Dai; G A Quamme
Journal:  Pflugers Arch       Date:  1994-05       Impact factor: 3.657

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.